2009 - 2010

2010

K. Kusi, B. Faber, V. Riasat, A. Thomas, C. Kocken and E. Remarque, Generation of Humoral Immune Responses to Multi-Allele PfAMA1 Vaccines; Effectof Adjuvant and Number of Component Alleles on the Breadth of Response. PLoS One, vol. 5, no. 11, 2010 (AMA1-DiCo)

Benjamin Mordmüller, Katja SzywonBenedikt Greutelaers, Meral Esen, Ludovic Mewono, Carolin Treut, Raymund E. Mürbeth, Roma Chilengi, Ramadhani Noor, Wen L. Kilama, Egeruan Babatunde ImoukhuedeNathalie ImbaultOdile Leroy, Michael Theisen, Søren Jepsen, Paul Milligan, Rolf Fendel, Peter G. Kremsner, Saadou Issifou.  Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambaréné, Gabon. Vaccine 2010, September, vol. 28, issue 41, 6698-703, Epub 2010 Aug 7. (GMZ2)

Sharmila Bakshi and Egeruan Babatunde Imoukhuede. Malaria Vectored Vaccines Consortium (MVVC). Human Vaccines: Current Opinion, vol. 6, issue 6 (MVVC)

Odile Leroy. Questions for European Vaccine Initiative. Human Vaccines: News, vol. 6, issue 6

Egeruan Babatunde Imoukhuede, Roland Ventura, Nathalie Imbault, Harry van Schooten, Odile Leroy, European Malaria Vaccine Initiative Portfolio and Perspectives for the Future. Human Vaccines, vol. 6, issue 1, 146-150 January 2010. 

2009

Meral Esen, Peter G. Kremsner, Regina Schleucher, Michael Gässler, Egeruan Babatunde ImoukhuedeNathalie ImbaultOdile Leroy, Søren Jepsen, Birgitte Walther Knudsen, Michael Schumm, Jürgen Knobloch, Michael Theisen, Benjamin Mordmüller. Safety and immunogenicity of GMZ2 - A MSP3-GLURP fusion protein malaria vaccine candidate. Vaccine. 2009 Nov 16;27(49):6862-8. Epub 2009 Sep 13. (GMZ2)